{"success":true,"query":"cancer immunotherapy","count":10,"total_found":239763,"articles":[{"pmid":"29860986","title":"Immunotherapy and Prevention of Pancreatic Cancer.","authors":["Morrison AH","Byrne KT","Vonderheide RH"],"journal":"Trends Cancer","pub_date":"2018 Jun","abstract_url":"https://pubmed.ncbi.nlm.nih.gov/29860986","doi":"10.1016/j.trecan.2018.04.001"},{"pmid":"40847226","title":"Cancer Immunotherapy-An Overview.","authors":["Kulkarni P","Do D","Shrestha S","Leach B","Salgia R"],"journal":"Cancer Treat Res","pub_date":"2025","abstract_url":"https://pubmed.ncbi.nlm.nih.gov/40847226","doi":"10.1007/978-3-031-97242-3_1"},{"pmid":"39361750","title":"Cancer immunotherapy by γδ T cells.","authors":["Hayday A","Dechanet-Merville J","Rossjohn J","Silva-Santos B"],"journal":"Science","pub_date":"2024 Oct 4","abstract_url":"https://pubmed.ncbi.nlm.nih.gov/39361750","doi":"10.1126/science.abq7248"},{"pmid":"31311655","title":"Integrative Approaches to Cancer Immunotherapy.","authors":["Szeto GL","Finley SD"],"journal":"Trends Cancer","pub_date":"2019 Jul","abstract_url":"https://pubmed.ncbi.nlm.nih.gov/31311655","doi":"10.1016/j.trecan.2019.05.010"},{"pmid":"30309862","title":"Mouse Models for Cancer Immunotherapy Research.","authors":["Olson B","Li Y","Lin Y","Liu ET","Patnaik A"],"journal":"Cancer Discov","pub_date":"2018 Nov","abstract_url":"https://pubmed.ncbi.nlm.nih.gov/30309862","doi":"10.1158/2159-8290.CD-18-0044"},{"pmid":"30523282","title":"Cancer immunoediting and resistance to T cell-based immunotherapy.","authors":["O'Donnell JS","Teng MWL","Smyth MJ"],"journal":"Nat Rev Clin Oncol","pub_date":"2019 Mar","abstract_url":"https://pubmed.ncbi.nlm.nih.gov/30523282","doi":"10.1038/s41571-018-0142-8"},{"pmid":"36290818","title":"The Role of Immunotherapy in Pancreatic Cancer.","authors":["Mukherji R","Debnath D","Hartley ML","Noel MS"],"journal":"Curr Oncol","pub_date":"2022 Sep 23","abstract_url":"https://pubmed.ncbi.nlm.nih.gov/36290818","doi":"10.3390/curroncol29100541"},{"pmid":"37232801","title":"Immunotherapy in Anal Cancer.","authors":["Dhawan N","Afzal MZ","Amin M"],"journal":"Curr Oncol","pub_date":"2023 Apr 27","abstract_url":"https://pubmed.ncbi.nlm.nih.gov/37232801","doi":"10.3390/curroncol30050343"},{"pmid":"37328642","title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy.","authors":["Yang K","Halima A","Chan TA"],"journal":"Nat Rev Clin Oncol","pub_date":"2023 Sep","abstract_url":"https://pubmed.ncbi.nlm.nih.gov/37328642","doi":"10.1038/s41571-023-00789-4"},{"pmid":"38232985","title":"Immunotherapy for Ovarian Cancer: Disappointing or Promising?","authors":["Deng M","Tang F","Chang X","Liu P","Ji X","Hao M","Wang Y","Yang R","Ma Q","Zhang Y","Miao J"],"journal":"Mol Pharm","pub_date":"2024 Feb 5","abstract_url":"https://pubmed.ncbi.nlm.nih.gov/38232985","doi":"10.1021/acs.molpharmaceut.3c00986"}],"source":"PubMed / NIH"}